SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A,
BIB 70.19+2.8%4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jibacoa who wrote (2244)2/11/2008 2:11:01 PM
From: Jibacoa  Read Replies (1) of 3722
 
POTP was up 46.66% & is still up 20% with volume now cloe to 4M , about 8x its ADV

bigcharts.marketwatch.com

It announced that it has received proxies sufficient to approve the pending merger transaction with DARA BioSciences. & a reverse stock split.

At a special meeting on Jan 28, stockholders of DARA approved the merger.POTP will change its name to DARA BioSciences.

There is now a NAZ deadline of Feb13 to allow POTP to close the merger with DARA and satisfy the listing criteria.<g>

POTP is trying to develop dipeptidyl peptidase inhibitors for use in cancer and type 2 diabetes.Its lead product candidate, talabostat is in PIII for treatment of metastatic NSLC. It is also trying to develop PT-630, a DPP inhibitor for the treatment of type 2 diabetes.

The stock trades around 0.75xBV. It is trying to get off the near term DT coming from the Oct 17 H at $0.53

bigcharts.marketwatch.com

The Jan 2001 H was $14.60

bigcharts.marketwatch.com

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext